Semble Secures £30M to Revolutionize European Healthcare Operations
June 5, 2026, 9:33 am
Location: United Kingdom, England, City of London
Employees: 10001+
Founded date: 1957
Healthcare technology company Semble recently closed a significant £30 million Series C funding round. European growth investor Revaia led the investment. Partech also joined the round as a new investor. Existing backers Mercia Ventures and Octopus Ventures reinforced their commitment. This capital fuels Semble's strategic expansion across the UK and Europe. It targets large healthcare groups. The company aims to solidify its position in the UK and France. Semble will advance its AI-powered care orchestration capabilities. Its platform already connects and manages care for over 10 million patients. It serves more than 1,700 healthcare organizations. Semble tackles deeply fragmented healthcare systems. It delivers a unified, efficient solution for outpatient providers. This investment marks a crucial step. It moves towards a more connected and patient-centered future in healthcare.
Semble, a prominent healthcare technology company, has secured a substantial £30 million in Series C funding. This significant investment aims to transform healthcare management across Europe. Revaia, a leading European growth investor, spearheaded the round. New investor Partech also joined the syndicate. Previous investors Mercia Ventures and Octopus Ventures demonstrated continued confidence. This capital injection underscores the growing demand for integrated health solutions.
The UK-based firm focuses on outpatient healthcare providers. Its platform unifies complex clinical and administrative workflows. Healthcare organizations traditionally grapple with disconnected systems. These fragmented technologies create inefficiencies. They compromise the patient experience. Semble offers a singular, cohesive platform. It orchestrates the entire patient journey. This includes everything from initial contact to follow-up care.
The company's impact is already substantial. Over 10 million patients have received care through Semble's platform. This represents a significant portion of the UK population. The platform is trusted by more than 1,700 healthcare organizations. Prominent names like Nuffield Health, Welbeck, Midland Health, and London Doctors Clinic utilize Semble’s technology. These organizations leverage Semble to streamline operations. They enhance patient outcomes.
Healthcare providers face immense operational pressure. Fragmented technology systems contribute significantly to this strain. Rising patient demand exacerbates the issue. A generational shift towards private medical insurance and self-pay models also reshapes the market. Semble directly addresses these challenges. It provides an intelligent orchestration layer. This layer connects disparate systems. It offers a seamless experience for both providers and patients.
The new funding will drive key strategic initiatives. Semble plans to expand its footprint among large healthcare groups. These groups often manage multiple facilities and complex patient populations. A unified platform becomes critical for their efficiency. The investment will also strengthen Semble’s market position in the UK. Furthermore, it will accelerate expansion in France. Semble's adaptable platform has already demonstrated strong regulatory compliance in France. This rapid adoption highlights its robust architecture.
AI innovation stands at the core of Semble's future. The company will significantly develop its AI-powered care orchestration capabilities. This aims to create a truly intelligent system. Such a system can predict needs, optimize resource allocation, and personalize care pathways. Semble envisions becoming the foundational AI orchestration layer. This layer will underpin modern healthcare delivery across Europe.
Interoperability is a hallmark of Semble's design. The platform integrates seamlessly with over 1,200 external tools. This includes diagnostics, billing, labs, and CRM systems. This open and flexible architecture makes Semble one of Europe’s most connected healthcare platforms. Healthcare providers increasingly seek interoperable infrastructure. Semble delivers this critical capability. It ensures data flows freely and securely.
Semble's growth trajectory has been impressive. The company increased its headcount by over 50% since December 2024. This rapid team expansion supports its ambitious growth plans. Such growth reflects the urgent market need for its solutions. Industry recognition also validates its approach. TIME named Semble one of the World’s Top HealthTech Companies for 2025. This accolade highlights its innovative solutions and market leadership.
Revaia’s leadership in the Series C round signals strong investor confidence. Investors recognize Semble’s potential. The company is building a system of action for modern healthcare. This platform boasts genuine clinical depth. It demonstrates real scale across the UK and France. The European healthcare market is undergoing profound transformation. Technology, demand, and shifting patient expectations drive this change. Semble is uniquely positioned to lead this evolution.
The investment reinforces the long-term vision. It supports the transformation of healthcare delivery. Semble helps healthcare organizations consolidate fragmented operational systems. It moves them towards unified platforms. This shift improves operational efficiency. It ultimately enhances the patient journey. The future of healthcare demands such integrated solutions.
Semble’s mission is clear. It aims to address deep fragmentation in care delivery. It connects and orchestrates every stage of the patient journey. This empowers solo clinicians, growing group practices, and complex enterprise organizations. They can deliver faster, safer, and more patient-centered care. This funding round accelerates that mission. It solidifies Semble’s role as a vital innovator in digital health. The company’s trajectory points towards continued market leadership. It redefines healthcare operations for a new era.
Semble, a prominent healthcare technology company, has secured a substantial £30 million in Series C funding. This significant investment aims to transform healthcare management across Europe. Revaia, a leading European growth investor, spearheaded the round. New investor Partech also joined the syndicate. Previous investors Mercia Ventures and Octopus Ventures demonstrated continued confidence. This capital injection underscores the growing demand for integrated health solutions.
The UK-based firm focuses on outpatient healthcare providers. Its platform unifies complex clinical and administrative workflows. Healthcare organizations traditionally grapple with disconnected systems. These fragmented technologies create inefficiencies. They compromise the patient experience. Semble offers a singular, cohesive platform. It orchestrates the entire patient journey. This includes everything from initial contact to follow-up care.
The company's impact is already substantial. Over 10 million patients have received care through Semble's platform. This represents a significant portion of the UK population. The platform is trusted by more than 1,700 healthcare organizations. Prominent names like Nuffield Health, Welbeck, Midland Health, and London Doctors Clinic utilize Semble’s technology. These organizations leverage Semble to streamline operations. They enhance patient outcomes.
Healthcare providers face immense operational pressure. Fragmented technology systems contribute significantly to this strain. Rising patient demand exacerbates the issue. A generational shift towards private medical insurance and self-pay models also reshapes the market. Semble directly addresses these challenges. It provides an intelligent orchestration layer. This layer connects disparate systems. It offers a seamless experience for both providers and patients.
The new funding will drive key strategic initiatives. Semble plans to expand its footprint among large healthcare groups. These groups often manage multiple facilities and complex patient populations. A unified platform becomes critical for their efficiency. The investment will also strengthen Semble’s market position in the UK. Furthermore, it will accelerate expansion in France. Semble's adaptable platform has already demonstrated strong regulatory compliance in France. This rapid adoption highlights its robust architecture.
AI innovation stands at the core of Semble's future. The company will significantly develop its AI-powered care orchestration capabilities. This aims to create a truly intelligent system. Such a system can predict needs, optimize resource allocation, and personalize care pathways. Semble envisions becoming the foundational AI orchestration layer. This layer will underpin modern healthcare delivery across Europe.
Interoperability is a hallmark of Semble's design. The platform integrates seamlessly with over 1,200 external tools. This includes diagnostics, billing, labs, and CRM systems. This open and flexible architecture makes Semble one of Europe’s most connected healthcare platforms. Healthcare providers increasingly seek interoperable infrastructure. Semble delivers this critical capability. It ensures data flows freely and securely.
Semble's growth trajectory has been impressive. The company increased its headcount by over 50% since December 2024. This rapid team expansion supports its ambitious growth plans. Such growth reflects the urgent market need for its solutions. Industry recognition also validates its approach. TIME named Semble one of the World’s Top HealthTech Companies for 2025. This accolade highlights its innovative solutions and market leadership.
Revaia’s leadership in the Series C round signals strong investor confidence. Investors recognize Semble’s potential. The company is building a system of action for modern healthcare. This platform boasts genuine clinical depth. It demonstrates real scale across the UK and France. The European healthcare market is undergoing profound transformation. Technology, demand, and shifting patient expectations drive this change. Semble is uniquely positioned to lead this evolution.
The investment reinforces the long-term vision. It supports the transformation of healthcare delivery. Semble helps healthcare organizations consolidate fragmented operational systems. It moves them towards unified platforms. This shift improves operational efficiency. It ultimately enhances the patient journey. The future of healthcare demands such integrated solutions.
Semble’s mission is clear. It aims to address deep fragmentation in care delivery. It connects and orchestrates every stage of the patient journey. This empowers solo clinicians, growing group practices, and complex enterprise organizations. They can deliver faster, safer, and more patient-centered care. This funding round accelerates that mission. It solidifies Semble’s role as a vital innovator in digital health. The company’s trajectory points towards continued market leadership. It redefines healthcare operations for a new era.